Overview

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.

Status:
Recruiting

Trial end date:
2023-12-15

Target enrollment:

Participant gender:

Summary

The purpose of the protocol, is to assess the safety and efficacy profile of IPN59011 compared to a placebo. IPN59011 is expected to work longer than product already marketed in the treatment of subjects with moderate to severe facial wrinkles.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Ipsen

Treatments:

abobotulinumtoxinA